Notification regarding unquoted securities - IVX
|
11 May 2023 at 9:05am
|
Change of Director's Interest Notice- Robert Merriel
|
2 May 2023 at 5:15pm
|
Section 708A Cleansing Statement
|
2 May 2023 at 5:05pm
|
Application for quotation of securities - IVX
|
2 May 2023 at 5:05pm
|
Activities Report and Appendix 4C
|
28 April 2023 at 9:40am
|
Invion launches Interactive Investor Hub
|
11 April 2023 at 9:15am
|
Results of General Meeting
|
6 April 2023 at 5:40pm
|
General Meeting Presentation
|
6 April 2023 at 10:30am
|
Notice of General Meeting/Proxy Form
|
7 March 2023 at 11:15am
|
Appendix 4D and Half Year Financial Report
|
23 February 2023 at 9:25am
|
Change of Director's Interest Notice- Alan Yamashita
|
13 February 2023 at 9:55am
|
Change of Director's Interest Notice - Thian Chew
|
13 February 2023 at 9:55am
|
Notification of cessation of securities - IVX
|
13 February 2023 at 9:55am
|
Expansion of Territory Rights to USA, Canada and Hong Kong
|
8 February 2023 at 8:50am
|
Activities Report and Appendix 4C
|
30 January 2023 at 9:05am
|
Notification regarding unquoted securities - IVX
|
20 January 2023 at 1:20pm
|
Change of Director's Interest Notice - Thian Chew
|
17 November 2022 at 2:50pm
|
Notification regarding unquoted securities - IVX
|
17 November 2022 at 2:40pm
|
New Constitution
|
17 November 2022 at 2:30pm
|
Results of Annual General Meeting
|
17 November 2022 at 2:20pm
|
AGM Presentation
|
17 November 2022 at 12:50pm
|
Invion Conference Presentation
|
27 October 2022 at 9:20am
|
Photosoft Effective Against Superbugs and Other Pathogens
|
26 October 2022 at 11:15am
|
Photosoft shows activity against Dengue in Preliminary Assay
|
24 October 2022 at 6:00pm
|
Invion Conference Presentation
|
18 October 2022 at 9:45am
|
Activities Report and Appendix 4C
|
17 October 2022 at 4:45pm
|
Notice of Annual General Meeting/Proxy Form
|
14 October 2022 at 9:35am
|
Change in substantial holding
|
10 October 2022 at 11:05am
|
Hudson Institute to Present Photosoft at Combio2022
|
27 September 2022 at 9:15am
|
Change of Director's Interest Notice - Alistair Bennallack
|
21 September 2022 at 9:30am
|
Section 708A Cleansing Statement
|
21 September 2022 at 9:30am
|
Application for quotation of securities - IVX
|
21 September 2022 at 9:20am
|
INV043 Effective Against Anal Cancer SCC In Vitro
|
15 September 2022 at 9:30am
|
Change of Director's Interest Notice - Alistair Bennallack
|
13 September 2022 at 4:05pm
|
Change of Director's Interest Notice- Alan Yamashita
|
13 September 2022 at 4:05pm
|
Change of Director's Interest Notice- Robert Merriel
|
13 September 2022 at 4:00pm
|
Change of Director's Interest Notice - Thian Chew
|
13 September 2022 at 4:00pm
|
Notification regarding unquoted securities - IVX
|
13 September 2022 at 3:25pm
|
Response to ASX Aware Query
|
13 September 2022 at 11:55am
|
Photosoft Shows Activity Against Zika Virus
|
8 September 2022 at 10:05am
|
Appendix 4G and Corporate Governance Statement
|
18 August 2022 at 9:20am
|
Appendix 4E and Annual Report
|
18 August 2022 at 9:15am
|
Activities Report and Appendix 4C
|
21 July 2022 at 9:20am
|
Investor Presentation
|
27 June 2022 at 1:45pm
|
Notification regarding unquoted securities - IVX
|
20 June 2022 at 10:05am
|
Change of Director's Interest Notice - Alistair Bennallack
|
20 June 2022 at 10:05am
|
Change of Director's Interest Notice - Robert Merriel
|
20 June 2022 at 10:05am
|
Change of Director's Interest Notice - Alan Yamashita
|
20 June 2022 at 10:05am
|
Change of Director's Interest Notice - Thian Chew
|
20 June 2022 at 10:05am
|
International Patent to Extend IP Protection for Photosoft
|
8 June 2022 at 9:45am
|